MedTrace Logo

A Prospective Cohort Study on Colorectal Cancer Screening in Community Population

NCT05485077 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 18000

Last updated 2024-04-17

No results posted yet for this study

Summary

This study will validate the real world results of polygene methylation detection in colorectal cancer in a large prospective community cohort. In this study, questionnaire survey and polygene methylation detection technology of colorectal cancer were used as preliminary screening methods, and colonoscopy was used as further validation examination method to screen colorectal cancer and precancerous lesions. The diagnosis and outcome of all lesions were based on colonoscopy and pathological examination.

Conditions

Sponsors & Collaborators

  • Peking University Shougang Hospital

    collaborator OTHER

  • Singlera Genomics Inc.

    lead INDUSTRY

Principal Investigators

  • Rui Liu, Doctor · Singlera Genomics Inc.

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-09
Primary Completion
2028-07-09
Completion
2028-07-09

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05485077 on ClinicalTrials.gov